183 related articles for article (PubMed ID: 20843279)
1. ABC transporters and cytochromes P450 in the human central nervous system: influence on brain pharmacokinetics and contribution to neurodegenerative disorders.
Dutheil F; Jacob A; Dauchy S; Beaune P; Scherrmann JM; Declèves X; Loriot MA
Expert Opin Drug Metab Toxicol; 2010 Oct; 6(10):1161-74. PubMed ID: 20843279
[TBL] [Abstract][Full Text] [Related]
2. Interplay of drug metabolizing CYP450 enzymes and ABC transporters in the blood-brain barrier.
Decleves X; Jacob A; Yousif S; Shawahna R; Potin S; Scherrmann JM
Curr Drug Metab; 2011 Oct; 12(8):732-41. PubMed ID: 21623707
[TBL] [Abstract][Full Text] [Related]
3. Xenobiotic metabolizing enzymes in the central nervous system: Contribution of cytochrome P450 enzymes in normal and pathological human brain.
Dutheil F; Beaune P; Loriot MA
Biochimie; 2008 Mar; 90(3):426-36. PubMed ID: 17997991
[TBL] [Abstract][Full Text] [Related]
4. Regulation of brain drug metabolizing enzymes and transporters by nuclear receptors.
Xu D; Huang S; Wang H; Xie W
Drug Metab Rev; 2018 Nov; 50(4):407-414. PubMed ID: 30501435
[TBL] [Abstract][Full Text] [Related]
5. ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier.
Dauchy S; Dutheil F; Weaver RJ; Chassoux F; Daumas-Duport C; Couraud PO; Scherrmann JM; De Waziers I; Declèves X
J Neurochem; 2008 Dec; 107(6):1518-28. PubMed ID: 19094056
[TBL] [Abstract][Full Text] [Related]
6. ABC transporters at the blood-brain barrier.
Mahringer A; Fricker G
Expert Opin Drug Metab Toxicol; 2016 May; 12(5):499-508. PubMed ID: 26998936
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 in the central nervous system as a therapeutic target in neurodegenerative diseases.
Navarro-Mabarak C; Camacho-Carranza R; Espinosa-Aguirre JJ
Drug Metab Rev; 2018 May; 50(2):95-108. PubMed ID: 29451034
[TBL] [Abstract][Full Text] [Related]
8. Dysfunction of ABC Transporters at the Surface of BBB: Potential Implications in Intractable Epilepsy and Applications of Nanotechnology Enabled Drug Delivery.
Mohi-Ud-Din R; Mir RH; Mir PA; Banday N; Shah AJ; Sawhney G; Bhat MM; Batiha GE; Pottoo FH
Curr Drug Metab; 2022; 23(9):735-756. PubMed ID: 35980054
[TBL] [Abstract][Full Text] [Related]
9. The role of ABC and SLC transporters in the pharmacokinetics of dietary and herbal phytochemicals and their interactions with xenobiotics.
Li Y; Lu J; Paxton JW
Curr Drug Metab; 2012 Jun; 13(5):624-39. PubMed ID: 22475331
[TBL] [Abstract][Full Text] [Related]
10. Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function.
Dutheil F; Dauchy S; Diry M; Sazdovitch V; Cloarec O; Mellottée L; Bièche I; Ingelman-Sundberg M; Flinois JP; de Waziers I; Beaune P; Declèves X; Duyckaerts C; Loriot MA
Drug Metab Dispos; 2009 Jul; 37(7):1528-38. PubMed ID: 19359404
[TBL] [Abstract][Full Text] [Related]
11. ATP-binding cassette transporters and neurodegenerative diseases.
Katzeff JS; Kim WS
Essays Biochem; 2021 Dec; 65(7):1013-1024. PubMed ID: 34415015
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 and Non-Cytochrome P450 Oxidative Metabolism: Contributions to the Pharmacokinetics, Safety, and Efficacy of Xenobiotics.
Foti RS; Dalvie DK
Drug Metab Dispos; 2016 Aug; 44(8):1229-45. PubMed ID: 27298339
[TBL] [Abstract][Full Text] [Related]
13. Regulation of ABC transporters at the blood-brain barrier.
Miller DS
Clin Pharmacol Ther; 2015 Apr; 97(4):395-403. PubMed ID: 25670036
[TBL] [Abstract][Full Text] [Related]
14. ATP-binding cassette transporters and their roles in protecting the brain.
ElAli A; Hermann DM
Neuroscientist; 2011 Aug; 17(4):423-36. PubMed ID: 21518814
[TBL] [Abstract][Full Text] [Related]
15. The ABC of the blood-brain barrier - regulation of drug efflux pumps.
Mahringer A; Ott M; Reimold I; Reichel V; Fricker G
Curr Pharm Des; 2011; 17(26):2762-70. PubMed ID: 21827407
[TBL] [Abstract][Full Text] [Related]
16. ABC transporters in human lymphocytes: expression, activity and role, modulating factors and consequences for antiretroviral therapies.
Giraud C; Manceau S; Treluyer JM
Expert Opin Drug Metab Toxicol; 2010 May; 6(5):571-89. PubMed ID: 20367109
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 enzymes and metabolism of drugs and neurotoxins within the mammalian brain.
Stocco MR; Tyndale RF
Adv Pharmacol; 2022; 95():73-106. PubMed ID: 35953164
[TBL] [Abstract][Full Text] [Related]
18. Targeting CNS transporters for treatment of neurodegenerative diseases.
Jedlitschky G; Grube M; Mosyagin I; Kroemer HK; Vogelgesang S
Curr Pharm Des; 2014; 20(10):1523-33. PubMed ID: 23789959
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of cytochromes P450, ABC transporters and their principal transcription factors in the amygdala and prefrontal cortex of alcoholics, smokers and drug-free controls by qRT-PCR.
Toselli F; de Waziers I; Dutheil M; Vincent M; Wilce PA; Dodd PR; Beaune P; Loriot MA; Gillam EM
Xenobiotica; 2015; 45(12):1129-37. PubMed ID: 26095139
[TBL] [Abstract][Full Text] [Related]
20. PET Tracers for Imaging of ABC Transporters at the Blood-Brain Barrier: Principles and Strategies.
Luurtsema G; Elsinga P; Dierckx R; Boellaard R; van Waarde A
Curr Pharm Des; 2016; 22(38):5779-5785. PubMed ID: 27568733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
